Privia Health Group (PRVA) Projected to Post Earnings on Thursday

Privia Health Group (NASDAQ:PRVA) is anticipated to release its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect Privia Health Group to post earnings of $0.04 per share and revenue of $516.6090 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 26, 2026 at 8:00 AM ET.

Privia Health Group Price Performance

PRVA opened at $21.78 on Thursday. Privia Health Group has a fifty-two week low of $18.77 and a fifty-two week high of $26.51. The company’s 50 day moving average price is $23.29 and its two-hundred day moving average price is $23.35. The firm has a market capitalization of $2.68 billion, a price-to-earnings ratio of 167.55, a PEG ratio of 1.55 and a beta of 0.83.

Wall Street Analyst Weigh In

PRVA has been the subject of several analyst reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Privia Health Group in a research report on Monday, December 29th. Wolfe Research set a $31.00 price objective on Privia Health Group in a research report on Tuesday, January 6th. Truist Financial reiterated a “buy” rating and issued a $31.00 target price (up from $30.00) on shares of Privia Health Group in a report on Monday, November 10th. Canaccord Genuity Group upped their price objective on shares of Privia Health Group from $32.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, November 12th. Finally, Citigroup reiterated a “market outperform” rating on shares of Privia Health Group in a research report on Tuesday, January 6th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Privia Health Group presently has an average rating of “Moderate Buy” and an average target price of $30.54.

Insider Buying and Selling at Privia Health Group

In other news, CFO David Mountcastle sold 23,887 shares of the stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $25.03, for a total transaction of $597,891.61. Following the transaction, the chief financial officer owned 172,909 shares of the company’s stock, valued at $4,327,912.27. This represents a 12.14% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Matthew Shawn Morris sold 13,647 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The stock was sold at an average price of $25.01, for a total value of $341,311.47. Following the transaction, the director directly owned 68,188 shares in the company, valued at approximately $1,705,381.88. This trade represents a 16.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 10.70% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of PRVA. Vanguard Personalized Indexing Management LLC lifted its stake in shares of Privia Health Group by 5.9% in the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 16,250 shares of the company’s stock valued at $385,000 after buying an additional 903 shares in the last quarter. Schroder Investment Management Group increased its position in shares of Privia Health Group by 0.8% during the fourth quarter. Schroder Investment Management Group now owns 140,038 shares of the company’s stock worth $3,341,000 after acquiring an additional 1,123 shares in the last quarter. Bradley Foster & Sargent Inc. CT boosted its stake in Privia Health Group by 3.3% during the 4th quarter. Bradley Foster & Sargent Inc. CT now owns 37,688 shares of the company’s stock valued at $894,000 after purchasing an additional 1,192 shares during the last quarter. Canada Pension Plan Investment Board increased its holdings in Privia Health Group by 48.0% during the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after purchasing an additional 1,200 shares in the last quarter. Finally, Natixis Advisors LLC raised its stake in shares of Privia Health Group by 6.4% in the fourth quarter. Natixis Advisors LLC now owns 20,352 shares of the company’s stock worth $483,000 after purchasing an additional 1,221 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.